March 23, 2026
As the life sciences sector moves through 2026, hiring demand across the United States and the United Kingdom continues to remain stronger than many expected. While funding conditions are more selective than during the peak biotech cycle, ongoing manufacturing expansion, MedTech growth, and continued investment in production capacity are still driving demand for experienced professionals across pharma, biotech, CDMO, and medical device organisations.
Recent announcements during the first quarter of 2026 confirm that companies are continuing to invest in biologics manufacturing, advanced therapies, medical technology production, and supply chain resilience, all of which require skilled talent across manufacturing, quality, validation, regulatory, engineering, and technical operations.
Manufacturing investment remains one of the biggest drivers of hiring activity across life sciences. Companies are continuing to expand production capacity in response to growing demand for biologics, cell and gene therapies, and specialty medicines.
In February 2026, AbbVie announced a $380 million expansion of its U.S. manufacturing facilities to support future pipeline medicines, with plans to hire engineers, scientists, operators, and technical staff as part of the project.
Large pharmaceutical companies are also investing globally in advanced therapy production, including cell therapy and radiopharmaceutical manufacturing, reflecting the shift toward more complex and specialised treatments.
These types of projects typically create long-term hiring demand across:
Industry reports continue to show that advanced manufacturing skills remain among the most in-demand capabilities in 2026.
Contract development and manufacturing organisations (CDMOs) continue to play a major role in the global life sciences supply chain, with many pharma and biotech companies choosing to outsource production rather than build internal capacity.
Recent forecasts from major CDMO providers show continued growth in contract manufacturing demand, particularly across biologics, sterile manufacturing, and complex drug products.
This outsourcing model supports hiring across both sponsors and manufacturing partners, especially in:
Even in a more cautious funding environment, pipeline progress and commercial launches continue to require production capability, which keeps demand for experienced professionals high.
In addition to pharma and biotech, MedTech and medical device companies are continuing to invest in digital health, diagnostics, AI-enabled systems, and advanced manufacturing.
Industry outlook reports for 2026 highlight strong product development activity in AI-driven diagnostics, connected devices, and next-generation medical technologies, all of which require specialised engineering, regulatory, and manufacturing expertise.
This is contributing to hiring demand across:
MedTech growth is also increasing the need for professionals who understand both engineering and regulated environments, making experienced candidates particularly valuable.
Another major trend shaping hiring in 2026 is the continued adoption of automation, AI, and digital manufacturing technologies.
Life sciences companies are investing in smarter production systems to improve efficiency, compliance, and scalability, especially in biologics and advanced therapies.
As a result, employers are increasingly looking for professionals with experience in:
This shift means that even when hiring volumes are more selective, the demand for specialised talent remains high.
Although the hiring market in 2026 is more disciplined than in previous years, the underlying demand for experienced life sciences professionals remains strong.
Industry outlooks show that companies are still expanding pipelines, investing in production, and pursuing partnerships, even while being more cautious with spending.
As a result, hiring remains active across the US and UK in areas such as:
For professionals with relevant experience, the market continues to offer strong opportunities, particularly in organisations focused on manufacturing growth, product development, and operational scale-up.
Manufacturing expansion, MedTech growth, and continued investment in production capacity are keeping hiring demand steady across the life sciences sector in 2026.
While the market is more selective than during previous growth cycles, the need for skilled professionals across manufacturing, quality, engineering, regulatory, and technical operations remains high, especially in the United States and the United Kingdom.
As long as companies continue to build facilities, launch products, and scale production, hiring demand across life sciences is expected to remain strong.
© All rights reserved